{"id":361317,"date":"2025-08-30T16:58:51","date_gmt":"2025-08-30T16:58:51","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-cullinan-therapeutics\/"},"modified":"2025-08-30T16:58:51","modified_gmt":"2025-08-30T16:58:51","slug":"how-to-buy-cullinan-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/","title":{"rendered":"How to buy Cullinan Therapeutics, Inc. (CGEM) shares &#8211; Investment in Cullinan Therapeutics, Inc. (CGEM) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-361317","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Cullinan Therapeutics, Inc. (CGEM) Shares - Investment in Cullinan Therapeutics, Inc. (CGEM) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Cullinan Therapeutics, Inc. (CGEM) Shares - Investment in Cullinan Therapeutics, Inc. (CGEM) Stock"},"description":"Learn how to buy Cullinan Therapeutics (CGEM) shares with current price $7.66. Discover investment strategies, risks, and growth potential for this biotech stock.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Cullinan Therapeutics (CGEM) shares with current price $7.66. Discover investment strategies, risks, and growth potential for this biotech stock."},"intro":"Thinking about investing in cutting-edge biotechnology? Cullinan Therapeutics represents the exciting frontier of autoimmune and cancer treatments. This clinical-stage biopharma company could either revolutionize medicine or test your patience\u2014but that's what makes biotech investing so thrilling! Let's explore whether CGEM belongs in your portfolio.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in cutting-edge biotechnology? Cullinan Therapeutics represents the exciting frontier of autoimmune and cancer treatments. This clinical-stage biopharma company could either revolutionize medicine or test your patience\u2014but that's what makes biotech investing so thrilling! Let's explore whether CGEM belongs in your portfolio."},"body_html":"<h2>\ud83d\udcc8 Cullinan Therapeutics Stock: Current Price and Critical Dates<\/h2> <p>As of August 30, 2025, Cullinan Therapeutics (CGEM) trades at <strong>$7.66<\/strong> per share. Mark your calendar: <strong>November 6, 2025<\/strong> is absolutely critical\u2014that's when the company releases its Q3 earnings. Historically, these reports have moved prices dramatically.<\/p> <p><strong>How Earnings Reports Impact CGEM Stock<\/strong><\/p> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>Aug 7, 2025<\/td><td>Q2 Earnings<\/td><td>$7.93<\/td><td>-4.8% (missed estimates)<\/td><\/tr> <tr><td>May 2025<\/td><td>Clinical Data<\/td><td>$8.50<\/td><td>+12% (positive results)<\/td><\/tr> <tr><td>Feb 2025<\/td><td>Partnership News<\/td><td>$9.80<\/td><td>-15% (market skepticism)<\/td><\/tr> <tr><td>Nov 2024<\/td><td>Previous Q3<\/td><td>$10.20<\/td><td>+8% (pipeline progress)<\/td><\/tr> <tr><td>Aug 2024<\/td><td>Q2 2024<\/td><td>$11.50<\/td><td>-6% (increased R&amp;D spend)<\/td><\/tr> <\/tbody> <\/table> <p>The pattern shows CGEM reacts strongly to clinical trial results and partnership announcements. The recent August miss created a buying opportunity for brave investors.<\/p>  [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey: Rollercoaster Ride<\/h2> <p>CGEM has been on a wild ride from January to August 2025:<\/p> <p><strong>January 2025<\/strong>: $12.98 (post-holiday optimism)<br\/> <strong>February 2025<\/strong>: $10.70 (-19.6%, partnership concerns)<br\/> <strong>March 2025<\/strong>: $9.38 (-10.8%, market volatility)<br\/> <strong>April 2025<\/strong>: $8.10 (+1.85%, slight recovery)<br\/> <strong>May 2025<\/strong>: $7.30 (-10%, earnings anticipation)<br\/> <strong>August 2025<\/strong>: $7.66 (current level, near 52-week low)<\/p> <p>Why the decline? Biotech stocks faced sector-wide pressure, plus CGEM's increased R&amp;D spending spooked short-term investors. But here's the secret: clinical-stage companies often dip before major catalysts.<\/p>  <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p><strong>2025 Target<\/strong>: $12-15 (pending November data readouts) \u2192 <strong>BUY<\/strong><br\/> <strong>2026 Projection<\/strong>: $18-22 (potential Phase 2 success)<br\/> <strong>2028 Outlook<\/strong>: $25-30 (possible FDA submissions)<br\/> <strong>2030 Vision<\/strong>: $35-40 (commercialization phase)<\/p> <p>The analyst consensus screams opportunity\u2014average price target of $26.57 represents <strong>247% upside potential<\/strong>! Seven analysts maintain \"Strong Buy\" ratings with zero sell recommendations.<\/p>  <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <p><strong>Risks to Consider:<\/strong><\/p> <ul> <li><strong>Clinical failure risk<\/strong>: 90% of drug candidates fail<\/li> <li><strong>Cash burn<\/strong>: $70.1M quarterly loss (<a href=\"https:\/\/www.biospace.com\/press-releases\/cullinan-therapeutics-provides-corporate-update-and-reports-second-quarter-2025-financial-results\">Q2 2025 Results<\/a>)<\/li> <li><strong>Dilution risk<\/strong>: May need to raise more capital<\/li> <li><strong>Regulatory hurdles<\/strong>: FDA approval uncertain<\/li> <\/ul> <p><strong>Green Lights for 2025:<\/strong><\/p> <ul> <li><strong>$510.9M cash runway<\/strong> into 2028 (<a href=\"https:\/\/www.stocktitan.net\/news\/CGEM\/cullinan-therapeutics-provides-corporate-update-and-reports-second-qtwpgjr5iemb.html\">Strong Balance Sheet<\/a>)<\/li> <li><strong>Multiple catalysts<\/strong>: IASLC WCLC and ESMO Congress data<\/li> <li><strong>New partnership<\/strong>: Velinotamig license from Genrix Bio<\/li> <li><strong>Analyst confidence<\/strong>: 100% buy ratings (<a href=\"https:\/\/www.marketbeat.com\/instant-alerts\/cullinan-therapeutics-inc-nasdaqcgem-given-average-rating-of-buy-by-analysts-2025-08-28\/\">MarketBeat Analysis<\/a>)<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start small<\/strong>: Allocate only 2-3% of your portfolio to high-risk biotech<\/li> <li><strong>Wait for November<\/strong>: Post-earnings dips often create better entry points<\/li> <li><strong>Diversify<\/strong>: Pair CGEM with established healthcare stocks for balance<\/li> <li><strong>Set alerts<\/strong>: Monitor clinical trial announcements like a hawk<\/li> <\/ol> <p>Humorous take: \"Trading CGEM is like dating a brilliant scientist\u2014incredible potential but occasionally forgets to call when working late in the lab!\"<\/p>  <h2>\u2705 How to Buy Cullinan Therapeutics, Inc. (CGEM) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NASDAQ listings and biotech stocks<\/td><\/tr> <tr><td>2<\/td><td>Complete account verification<\/td><td>Usually takes 1-2 business days for stock trading<\/td><\/tr> <tr><td>3<\/td><td>Deposit funds<\/td><td>Start with an amount you're comfortable potentially losing<\/td><\/tr> <tr><td>4<\/td><td>Search \"CGEM\"<\/td><td>Use the ticker symbol, not just the company name<\/td><\/tr> <tr><td>5<\/td><td>Select order type<\/td><td>Limit orders prevent overpaying during volatility<\/td><\/tr> <tr><td>6<\/td><td>Review and confirm<\/td><td>Check commission fees\u2014many platforms offer $0 trades<\/td><\/tr> <tr><td>7<\/td><td>Monitor position<\/td><td>Set price alerts for earnings and clinical updates<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Why Pocket Option Appeals to New Investors<\/h2> <p>Pocket Option simplifies stock access for beginners:<\/p> <ul> <li><strong>$5 minimum deposit<\/strong>\u2014test strategies with minimal risk<\/li> <li><strong>1-document KYC<\/strong>\u2014start trading within minutes<\/li> <li><strong>100+ withdrawal methods<\/strong>\u2014flexibility with your profits<\/li> <li><strong>Fractional shares available<\/strong>\u2014buy pieces of expensive stocks<\/li> <\/ul> <p>The platform's user-friendly interface makes navigating biotech volatility less intimidating for newcomers.<\/p>  <h2>\ud83c\udf0d Cullinan Therapeutics in 2025: Pipeline Powerhouse<\/h2> <p>Cullinan dominates the T-cell engager space with two promising platforms:<\/p> <ul> <li><strong>CLN-978<\/strong>: Phase 1 trials for lupus, arthritis, and Sj\u00f6gren's disease<\/li> <li><strong>Zipalertinib<\/strong>: Lung cancer treatment with Taiho Oncology partnership<\/li> <\/ul> <p>The company's <a href=\"https:\/\/www.directorstalkinterviews.com\/cullinan-therapeutics-cgem-stock-analysis-a-biotech-play-with-a-241-88-upside-potential\/4121213238\">modality-agnostic approach<\/a> allows them to target multiple diseases with similar technology. Current market cap of ~$450M seems undervalued given the pipeline potential.<\/p> <p><strong>Interesting Fact<\/strong>: In 2025, Cullinan's research team discovered that their T-cell engager technology could potentially treat three autoimmune diseases simultaneously\u2014something never achieved before in medicine!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Cullinan Therapeutics Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 30, 2025, Cullinan Therapeutics (CGEM) trades at <strong>$7.66<\/strong> per share. Mark your calendar: <strong>November 6, 2025<\/strong> is absolutely critical\u2014that&#8217;s when the company releases its Q3 earnings. Historically, these reports have moved prices dramatically.<\/p>\n<p><strong>How Earnings Reports Impact CGEM Stock<\/strong><\/p>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Aug 7, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>$7.93<\/td>\n<td>-4.8% (missed estimates)<\/td>\n<\/tr>\n<tr>\n<td>May 2025<\/td>\n<td>Clinical Data<\/td>\n<td>$8.50<\/td>\n<td>+12% (positive results)<\/td>\n<\/tr>\n<tr>\n<td>Feb 2025<\/td>\n<td>Partnership News<\/td>\n<td>$9.80<\/td>\n<td>-15% (market skepticism)<\/td>\n<\/tr>\n<tr>\n<td>Nov 2024<\/td>\n<td>Previous Q3<\/td>\n<td>$10.20<\/td>\n<td>+8% (pipeline progress)<\/td>\n<\/tr>\n<tr>\n<td>Aug 2024<\/td>\n<td>Q2 2024<\/td>\n<td>$11.50<\/td>\n<td>-6% (increased R&amp;D spend)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The pattern shows CGEM reacts strongly to clinical trial results and partnership announcements. The recent August miss created a buying opportunity for brave investors.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey: Rollercoaster Ride<\/h2>\n<p>CGEM has been on a wild ride from January to August 2025:<\/p>\n<p><strong>January 2025<\/strong>: $12.98 (post-holiday optimism)<br \/> <strong>February 2025<\/strong>: $10.70 (-19.6%, partnership concerns)<br \/> <strong>March 2025<\/strong>: $9.38 (-10.8%, market volatility)<br \/> <strong>April 2025<\/strong>: $8.10 (+1.85%, slight recovery)<br \/> <strong>May 2025<\/strong>: $7.30 (-10%, earnings anticipation)<br \/> <strong>August 2025<\/strong>: $7.66 (current level, near 52-week low)<\/p>\n<p>Why the decline? Biotech stocks faced sector-wide pressure, plus CGEM&#8217;s increased R&amp;D spending spooked short-term investors. But here&#8217;s the secret: clinical-stage companies often dip before major catalysts.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p><strong>2025 Target<\/strong>: $12-15 (pending November data readouts) \u2192 <strong>BUY<\/strong><br \/> <strong>2026 Projection<\/strong>: $18-22 (potential Phase 2 success)<br \/> <strong>2028 Outlook<\/strong>: $25-30 (possible FDA submissions)<br \/> <strong>2030 Vision<\/strong>: $35-40 (commercialization phase)<\/p>\n<p>The analyst consensus screams opportunity\u2014average price target of $26.57 represents <strong>247% upside potential<\/strong>! Seven analysts maintain &#8220;Strong Buy&#8221; ratings with zero sell recommendations.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<p><strong>Risks to Consider:<\/strong><\/p>\n<ul>\n<li><strong>Clinical failure risk<\/strong>: 90% of drug candidates fail<\/li>\n<li><strong>Cash burn<\/strong>: $70.1M quarterly loss (<a href=\"https:\/\/www.biospace.com\/press-releases\/cullinan-therapeutics-provides-corporate-update-and-reports-second-quarter-2025-financial-results\">Q2 2025 Results<\/a>)<\/li>\n<li><strong>Dilution risk<\/strong>: May need to raise more capital<\/li>\n<li><strong>Regulatory hurdles<\/strong>: FDA approval uncertain<\/li>\n<\/ul>\n<p><strong>Green Lights for 2025:<\/strong><\/p>\n<ul>\n<li><strong>$510.9M cash runway<\/strong> into 2028 (<a href=\"https:\/\/www.stocktitan.net\/news\/CGEM\/cullinan-therapeutics-provides-corporate-update-and-reports-second-qtwpgjr5iemb.html\">Strong Balance Sheet<\/a>)<\/li>\n<li><strong>Multiple catalysts<\/strong>: IASLC WCLC and ESMO Congress data<\/li>\n<li><strong>New partnership<\/strong>: Velinotamig license from Genrix Bio<\/li>\n<li><strong>Analyst confidence<\/strong>: 100% buy ratings (<a href=\"https:\/\/www.marketbeat.com\/instant-alerts\/cullinan-therapeutics-inc-nasdaqcgem-given-average-rating-of-buy-by-analysts-2025-08-28\/\">MarketBeat Analysis<\/a>)<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start small<\/strong>: Allocate only 2-3% of your portfolio to high-risk biotech<\/li>\n<li><strong>Wait for November<\/strong>: Post-earnings dips often create better entry points<\/li>\n<li><strong>Diversify<\/strong>: Pair CGEM with established healthcare stocks for balance<\/li>\n<li><strong>Set alerts<\/strong>: Monitor clinical trial announcements like a hawk<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading CGEM is like dating a brilliant scientist\u2014incredible potential but occasionally forgets to call when working late in the lab!&#8221;<\/p>\n<h2>\u2705 How to Buy Cullinan Therapeutics, Inc. (CGEM) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NASDAQ listings and biotech stocks<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account verification<\/td>\n<td>Usually takes 1-2 business days for stock trading<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Deposit funds<\/td>\n<td>Start with an amount you&#8217;re comfortable potentially losing<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search &#8220;CGEM&#8221;<\/td>\n<td>Use the ticker symbol, not just the company name<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Select order type<\/td>\n<td>Limit orders prevent overpaying during volatility<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Review and confirm<\/td>\n<td>Check commission fees\u2014many platforms offer $0 trades<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Monitor position<\/td>\n<td>Set price alerts for earnings and clinical updates<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Appeals to New Investors<\/h2>\n<p>Pocket Option simplifies stock access for beginners:<\/p>\n<ul>\n<li><strong>$5 minimum deposit<\/strong>\u2014test strategies with minimal risk<\/li>\n<li><strong>1-document KYC<\/strong>\u2014start trading within minutes<\/li>\n<li><strong>100+ withdrawal methods<\/strong>\u2014flexibility with your profits<\/li>\n<li><strong>Fractional shares available<\/strong>\u2014buy pieces of expensive stocks<\/li>\n<\/ul>\n<p>The platform&#8217;s user-friendly interface makes navigating biotech volatility less intimidating for newcomers.<\/p>\n<h2>\ud83c\udf0d Cullinan Therapeutics in 2025: Pipeline Powerhouse<\/h2>\n<p>Cullinan dominates the T-cell engager space with two promising platforms:<\/p>\n<ul>\n<li><strong>CLN-978<\/strong>: Phase 1 trials for lupus, arthritis, and Sj\u00f6gren&#8217;s disease<\/li>\n<li><strong>Zipalertinib<\/strong>: Lung cancer treatment with Taiho Oncology partnership<\/li>\n<\/ul>\n<p>The company&#8217;s <a href=\"https:\/\/www.directorstalkinterviews.com\/cullinan-therapeutics-cgem-stock-analysis-a-biotech-play-with-a-241-88-upside-potential\/4121213238\">modality-agnostic approach<\/a> allows them to target multiple diseases with similar technology. Current market cap of ~$450M seems undervalued given the pipeline potential.<\/p>\n<p><strong>Interesting Fact<\/strong>: In 2025, Cullinan&#8217;s research team discovered that their T-cell engager technology could potentially treat three autoimmune diseases simultaneously\u2014something never achieved before in medicine!<\/p>\n"},"faq":[{"question":"How much money do I need to start investing in CGEM?","answer":"You can start with as little as $50-$100 through fractional shares, though I recommend $500+ for proper position sizing."},{"question":"Is Cullinan Therapeutics profitable?","answer":"Not yet\u2014they're a clinical-stage company spending heavily on R&D ($61M last quarter). Profitability comes after drug approvals."},{"question":"What's the biggest risk with CGEM stock?","answer":"Clinical trial failures. If their main drug candidates don't work, the stock could decline significantly."},{"question":"How often does CGEM report earnings?","answer":"Quarterly like most public companies. Next report is November 6, 2025."},{"question":"Should I buy before or after earnings?","answer":"After is generally safer for beginners\u2014you avoid surprise misses like the recent -$1.07 EPS disappointment."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"How much money do I need to start investing in CGEM?","answer":"You can start with as little as $50-$100 through fractional shares, though I recommend $500+ for proper position sizing."},{"question":"Is Cullinan Therapeutics profitable?","answer":"Not yet\u2014they're a clinical-stage company spending heavily on R&D ($61M last quarter). Profitability comes after drug approvals."},{"question":"What's the biggest risk with CGEM stock?","answer":"Clinical trial failures. If their main drug candidates don't work, the stock could decline significantly."},{"question":"How often does CGEM report earnings?","answer":"Quarterly like most public companies. Next report is November 6, 2025."},{"question":"Should I buy before or after earnings?","answer":"After is generally safer for beginners\u2014you avoid surprise misses like the recent -$1.07 EPS disappointment."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Cullinan Therapeutics, Inc. (CGEM) shares - Investment in Cullinan Therapeutics, Inc. (CGEM) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Cullinan Therapeutics, Inc. (CGEM) shares - Investment in Cullinan Therapeutics, Inc. (CGEM) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-30T16:58:51+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Cullinan Therapeutics, Inc. (CGEM) shares &#8211; Investment in Cullinan Therapeutics, Inc. (CGEM) stock\",\"datePublished\":\"2025-08-30T16:58:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/\",\"name\":\"How to buy Cullinan Therapeutics, Inc. (CGEM) shares - Investment in Cullinan Therapeutics, Inc. (CGEM) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"datePublished\":\"2025-08-30T16:58:51+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Cullinan Therapeutics, Inc. (CGEM) shares &#8211; Investment in Cullinan Therapeutics, Inc. (CGEM) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Cullinan Therapeutics, Inc. (CGEM) shares - Investment in Cullinan Therapeutics, Inc. (CGEM) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Cullinan Therapeutics, Inc. (CGEM) shares - Investment in Cullinan Therapeutics, Inc. (CGEM) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-30T16:58:51+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Cullinan Therapeutics, Inc. (CGEM) shares &#8211; Investment in Cullinan Therapeutics, Inc. (CGEM) stock","datePublished":"2025-08-30T16:58:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/","name":"How to buy Cullinan Therapeutics, Inc. (CGEM) shares - Investment in Cullinan Therapeutics, Inc. (CGEM) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","datePublished":"2025-08-30T16:58:51+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Cullinan Therapeutics, Inc. (CGEM) shares &#8211; Investment in Cullinan Therapeutics, Inc. (CGEM) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":361333,"slug":"how-to-buy-cullinan-therapeutics","post_title":"Comment acheter des actions de Cullinan Therapeutics, Inc. (CGEM) - Investir dans les actions de Cullinan Therapeutics, Inc. (CGEM)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/"},"it_IT":{"locale":"it_IT","id":361335,"slug":"how-to-buy-cullinan-therapeutics","post_title":"Come acquistare azioni Cullinan Therapeutics, Inc. (CGEM) - Investire in azioni Cullinan Therapeutics, Inc. (CGEM)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/"},"pl_PL":{"locale":"pl_PL","id":361334,"slug":"how-to-buy-cullinan-therapeutics","post_title":"Jak kupi\u0107 akcje Cullinan Therapeutics, Inc. (CGEM) - Inwestycja w akcje Cullinan Therapeutics, Inc. (CGEM)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/"},"es_ES":{"locale":"es_ES","id":361337,"slug":"how-to-buy-cullinan-therapeutics","post_title":"C\u00f3mo comprar acciones de Cullinan Therapeutics, Inc. (CGEM) - Inversi\u00f3n en acciones de Cullinan Therapeutics, Inc. (CGEM)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/"},"th_TH":{"locale":"th_TH","id":361341,"slug":"how-to-buy-cullinan-therapeutics","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Cullinan Therapeutics, Inc. (CGEM) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Cullinan Therapeutics, Inc. (CGEM)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/"},"tr_TR":{"locale":"tr_TR","id":361338,"slug":"how-to-buy-cullinan-therapeutics","post_title":"Cullinan Therapeutics, Inc. (CGEM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Cullinan Therapeutics, Inc. (CGEM) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/"},"vt_VT":{"locale":"vt_VT","id":361339,"slug":"how-to-buy-cullinan-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cullinan Therapeutics, Inc. (CGEM) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cullinan Therapeutics, Inc. (CGEM)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":361336,"slug":"how-to-buy-cullinan-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Cullinan Therapeutics, Inc. (CGEM) - Investimento em a\u00e7\u00f5es da Cullinan Therapeutics, Inc. (CGEM)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-cullinan-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/361317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=361317"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/361317\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334108"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=361317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=361317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=361317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}